BioMarin Europe Limited/BioMarin Latin America
Commercializing Therapeutics for Rare Diseases
BioMarin's global sales team oversees the sales and distribution of Naglazyme in more than 30 countries around the world.
BioMarin Europe Limited, headquartered in Dublin, Ireland, operates an administrative office in London and branch offices in England, Germany, Italy, Spain, Portugal and Switzerland, serving patients in the 27 member states of the European Union, Iceland and Norway.
BioMarin Brasil Farmacêutica in Sao Paulo serves the growing Naglazyme patient population throughout Latin America.
To discuss potential partnership opportunities with BioMarin Europe Limited, please contact our Business Development group at email@example.com.